The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Preclinical Positron Emission Tomography (PET) Market Research Report 2025
Synopsis
PET creates three-dimensional (3D) images of a subject using radioactive tracers – molecules bound to a radioactive isotope – that are usually injected intravenously. The carrier molecule can bind to specific proteins, receptors, and biomolecular pathways in the body, to quantify a specific biological activity.
The global Preclinical Positron Emission Tomography (PET) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Preclinical Positron Emission Tomography (PET), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Positron Emission Tomography (PET).
Report Scope
The Preclinical Positron Emission Tomography (PET) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preclinical Positron Emission Tomography (PET) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical Positron Emission Tomography (PET) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
TriFoil Imaging
Bruker Corporation
Mediso
Spectral Instruments Imaging
MR Solutions
Aspect Imaging
Segment by Type
Structural Imaging
Functional Imaging
Segment by Application
Pharmaceutical Companies
Contract Research Organization (CRO’s)
Biotech Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical Positron Emission Tomography (PET) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
PET creates three-dimensional (3D) images of a subject using radioactive tracers – molecules bound to a radioactive isotope – that are usually injected intravenously. The carrier molecule can bind to specific proteins, receptors, and biomolecular pathways in the body, to quantify a specific biological activity.
The global Preclinical Positron Emission Tomography (PET) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Preclinical Positron Emission Tomography (PET), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Positron Emission Tomography (PET).
Report Scope
The Preclinical Positron Emission Tomography (PET) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preclinical Positron Emission Tomography (PET) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical Positron Emission Tomography (PET) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
TriFoil Imaging
Bruker Corporation
Mediso
Spectral Instruments Imaging
MR Solutions
Aspect Imaging
Segment by Type
Structural Imaging
Functional Imaging
Segment by Application
Pharmaceutical Companies
Contract Research Organization (CRO’s)
Biotech Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical Positron Emission Tomography (PET) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical Positron Emission Tomography (PET) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Structural Imaging
1.2.3 Functional Imaging
1.3 Market by Application
1.3.1 Global Preclinical Positron Emission Tomography (PET) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Contract Research Organization (CRO’s)
1.3.4 Biotech Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical Positron Emission Tomography (PET) Market Perspective (2019-2030)
2.2 Preclinical Positron Emission Tomography (PET) Growth Trends by Region
2.2.1 Global Preclinical Positron Emission Tomography (PET) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Preclinical Positron Emission Tomography (PET) Historic Market Size by Region (2019-2024)
2.2.3 Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Region (2025-2030)
2.3 Preclinical Positron Emission Tomography (PET) Market Dynamics
2.3.1 Preclinical Positron Emission Tomography (PET) Industry Trends
2.3.2 Preclinical Positron Emission Tomography (PET) Market Drivers
2.3.3 Preclinical Positron Emission Tomography (PET) Market Challenges
2.3.4 Preclinical Positron Emission Tomography (PET) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical Positron Emission Tomography (PET) Players by Revenue
3.1.1 Global Top Preclinical Positron Emission Tomography (PET) Players by Revenue (2019-2024)
3.1.2 Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Players (2019-2024)
3.2 Global Preclinical Positron Emission Tomography (PET) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preclinical Positron Emission Tomography (PET) Revenue
3.4 Global Preclinical Positron Emission Tomography (PET) Market Concentration Ratio
3.4.1 Global Preclinical Positron Emission Tomography (PET) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical Positron Emission Tomography (PET) Revenue in 2023
3.5 Preclinical Positron Emission Tomography (PET) Key Players Head office and Area Served
3.6 Key Players Preclinical Positron Emission Tomography (PET) Product Solution and Service
3.7 Date of Enter into Preclinical Positron Emission Tomography (PET) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical Positron Emission Tomography (PET) Breakdown Data by Type
4.1 Global Preclinical Positron Emission Tomography (PET) Historic Market Size by Type (2019-2024)
4.2 Global Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Type (2025-2030)
5 Preclinical Positron Emission Tomography (PET) Breakdown Data by Application
5.1 Global Preclinical Positron Emission Tomography (PET) Historic Market Size by Application (2019-2024)
5.2 Global Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Preclinical Positron Emission Tomography (PET) Market Size (2019-2030)
6.2 North America Preclinical Positron Emission Tomography (PET) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Preclinical Positron Emission Tomography (PET) Market Size by Country (2019-2024)
6.4 North America Preclinical Positron Emission Tomography (PET) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preclinical Positron Emission Tomography (PET) Market Size (2019-2030)
7.2 Europe Preclinical Positron Emission Tomography (PET) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Preclinical Positron Emission Tomography (PET) Market Size by Country (2019-2024)
7.4 Europe Preclinical Positron Emission Tomography (PET) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size (2019-2030)
8.2 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Region (2019-2024)
8.4 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preclinical Positron Emission Tomography (PET) Market Size (2019-2030)
9.2 Latin America Preclinical Positron Emission Tomography (PET) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Country (2019-2024)
9.4 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size (2019-2030)
10.2 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Country (2019-2024)
10.4 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 TriFoil Imaging
11.1.1 TriFoil Imaging Company Detail
11.1.2 TriFoil Imaging Business Overview
11.1.3 TriFoil Imaging Preclinical Positron Emission Tomography (PET) Introduction
11.1.4 TriFoil Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2019-2024)
11.1.5 TriFoil Imaging Recent Development
11.2 Bruker Corporation
11.2.1 Bruker Corporation Company Detail
11.2.2 Bruker Corporation Business Overview
11.2.3 Bruker Corporation Preclinical Positron Emission Tomography (PET) Introduction
11.2.4 Bruker Corporation Revenue in Preclinical Positron Emission Tomography (PET) Business (2019-2024)
11.2.5 Bruker Corporation Recent Development
11.3 Mediso
11.3.1 Mediso Company Detail
11.3.2 Mediso Business Overview
11.3.3 Mediso Preclinical Positron Emission Tomography (PET) Introduction
11.3.4 Mediso Revenue in Preclinical Positron Emission Tomography (PET) Business (2019-2024)
11.3.5 Mediso Recent Development
11.4 Spectral Instruments Imaging
11.4.1 Spectral Instruments Imaging Company Detail
11.4.2 Spectral Instruments Imaging Business Overview
11.4.3 Spectral Instruments Imaging Preclinical Positron Emission Tomography (PET) Introduction
11.4.4 Spectral Instruments Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2019-2024)
11.4.5 Spectral Instruments Imaging Recent Development
11.5 MR Solutions
11.5.1 MR Solutions Company Detail
11.5.2 MR Solutions Business Overview
11.5.3 MR Solutions Preclinical Positron Emission Tomography (PET) Introduction
11.5.4 MR Solutions Revenue in Preclinical Positron Emission Tomography (PET) Business (2019-2024)
11.5.5 MR Solutions Recent Development
11.6 Aspect Imaging
11.6.1 Aspect Imaging Company Detail
11.6.2 Aspect Imaging Business Overview
11.6.3 Aspect Imaging Preclinical Positron Emission Tomography (PET) Introduction
11.6.4 Aspect Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2019-2024)
11.6.5 Aspect Imaging Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Preclinical Positron Emission Tomography (PET) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Structural Imaging
Table 3. Key Players of Functional Imaging
Table 4. Global Preclinical Positron Emission Tomography (PET) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Preclinical Positron Emission Tomography (PET) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Preclinical Positron Emission Tomography (PET) Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Preclinical Positron Emission Tomography (PET) Market Share by Region (2019-2024)
Table 8. Global Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Preclinical Positron Emission Tomography (PET) Market Share by Region (2025-2030)
Table 10. Preclinical Positron Emission Tomography (PET) Market Trends
Table 11. Preclinical Positron Emission Tomography (PET) Market Drivers
Table 12. Preclinical Positron Emission Tomography (PET) Market Challenges
Table 13. Preclinical Positron Emission Tomography (PET) Market Restraints
Table 14. Global Preclinical Positron Emission Tomography (PET) Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Preclinical Positron Emission Tomography (PET) Market Share by Players (2019-2024)
Table 16. Global Top Preclinical Positron Emission Tomography (PET) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Positron Emission Tomography (PET) as of 2023)
Table 17. Ranking of Global Top Preclinical Positron Emission Tomography (PET) Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Preclinical Positron Emission Tomography (PET) Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Preclinical Positron Emission Tomography (PET) Product Solution and Service
Table 21. Date of Enter into Preclinical Positron Emission Tomography (PET) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Preclinical Positron Emission Tomography (PET) Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Type (2019-2024)
Table 25. Global Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Type (2025-2030)
Table 27. Global Preclinical Positron Emission Tomography (PET) Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Application (2019-2024)
Table 29. Global Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Application (2025-2030)
Table 31. North America Preclinical Positron Emission Tomography (PET) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Preclinical Positron Emission Tomography (PET) Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Preclinical Positron Emission Tomography (PET) Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Preclinical Positron Emission Tomography (PET) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Preclinical Positron Emission Tomography (PET) Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Preclinical Positron Emission Tomography (PET) Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Preclinical Positron Emission Tomography (PET) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Preclinical Positron Emission Tomography (PET) Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Preclinical Positron Emission Tomography (PET) Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Country (2025-2030) & (US$ Million)
Table 46. TriFoil Imaging Company Detail
Table 47. TriFoil Imaging Business Overview
Table 48. TriFoil Imaging Preclinical Positron Emission Tomography (PET) Product
Table 49. TriFoil Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2019-2024) & (US$ Million)
Table 50. TriFoil Imaging Recent Development
Table 51. Bruker Corporation Company Detail
Table 52. Bruker Corporation Business Overview
Table 53. Bruker Corporation Preclinical Positron Emission Tomography (PET) Product
Table 54. Bruker Corporation Revenue in Preclinical Positron Emission Tomography (PET) Business (2019-2024) & (US$ Million)
Table 55. Bruker Corporation Recent Development
Table 56. Mediso Company Detail
Table 57. Mediso Business Overview
Table 58. Mediso Preclinical Positron Emission Tomography (PET) Product
Table 59. Mediso Revenue in Preclinical Positron Emission Tomography (PET) Business (2019-2024) & (US$ Million)
Table 60. Mediso Recent Development
Table 61. Spectral Instruments Imaging Company Detail
Table 62. Spectral Instruments Imaging Business Overview
Table 63. Spectral Instruments Imaging Preclinical Positron Emission Tomography (PET) Product
Table 64. Spectral Instruments Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2019-2024) & (US$ Million)
Table 65. Spectral Instruments Imaging Recent Development
Table 66. MR Solutions Company Detail
Table 67. MR Solutions Business Overview
Table 68. MR Solutions Preclinical Positron Emission Tomography (PET) Product
Table 69. MR Solutions Revenue in Preclinical Positron Emission Tomography (PET) Business (2019-2024) & (US$ Million)
Table 70. MR Solutions Recent Development
Table 71. Aspect Imaging Company Detail
Table 72. Aspect Imaging Business Overview
Table 73. Aspect Imaging Preclinical Positron Emission Tomography (PET) Product
Table 74. Aspect Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2019-2024) & (US$ Million)
Table 75. Aspect Imaging Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preclinical Positron Emission Tomography (PET) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Preclinical Positron Emission Tomography (PET) Market Share by Type: 2023 VS 2030
Figure 3. Structural Imaging Features
Figure 4. Functional Imaging Features
Figure 5. Global Preclinical Positron Emission Tomography (PET) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Preclinical Positron Emission Tomography (PET) Market Share by Application: 2023 VS 2030
Figure 7. Pharmaceutical Companies Case Studies
Figure 8. Contract Research Organization (CRO’s) Case Studies
Figure 9. Biotech Companies Case Studies
Figure 10. Others Case Studies
Figure 11. Preclinical Positron Emission Tomography (PET) Report Years Considered
Figure 12. Global Preclinical Positron Emission Tomography (PET) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Preclinical Positron Emission Tomography (PET) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Preclinical Positron Emission Tomography (PET) Market Share by Region: 2023 VS 2030
Figure 15. Global Preclinical Positron Emission Tomography (PET) Market Share by Players in 2023
Figure 16. Global Top Preclinical Positron Emission Tomography (PET) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Positron Emission Tomography (PET) as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Preclinical Positron Emission Tomography (PET) Revenue in 2023
Figure 18. North America Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Preclinical Positron Emission Tomography (PET) Market Share by Country (2019-2030)
Figure 20. United States Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Preclinical Positron Emission Tomography (PET) Market Share by Country (2019-2030)
Figure 24. Germany Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Share by Region (2019-2030)
Figure 32. China Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Preclinical Positron Emission Tomography (PET) Market Share by Country (2019-2030)
Figure 40. Mexico Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Share by Country (2019-2030)
Figure 44. Turkey Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. TriFoil Imaging Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2019-2024)
Figure 47. Bruker Corporation Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2019-2024)
Figure 48. Mediso Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2019-2024)
Figure 49. Spectral Instruments Imaging Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2019-2024)
Figure 50. MR Solutions Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2019-2024)
Figure 51. Aspect Imaging Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
